NASDAQ:BIOL
Biolase Stock News
$0.148
+0.0038 (+2.63%)
At Close: May 02, 2024
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced data published in the Journal of Periodontology from a clinical trial conducted at The McGuire Institute™. Designed
Stocks To Watch: Bank Earnings And SPAC Deals Blaze In
08:25am, Saturday, 11'th Jul 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday
BIOLASE to Present at COVID-19 Webinar Hosted by Maxim Group on July 16, 2020
10:30am, Thursday, 09'th Jul 2020
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that BIOLASE CEO Todd Norbe has been invited to participate in a panel discussion on Re-Engaging Medical Practices in
BIOLASE's Epic Hygiene Laser Meets Guidelines to Minimize Risk of COVID-19 Transmission
01:00pm, Wednesday, 08'th Jul 2020
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that the Epic Hygiene dental laser meets recent guidance from the Center for Disease Control (CDC), which recommends n
BIOLASE, Inc. Announces Commencement of Rights Offering Subscription Period
10:30am, Thursday, 02'nd Jul 2020
BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, today announced that the subscription period for the rights offering has commenced. If exercising subscription rights through a broker,
Carlsmed Raises $2.5M to Improve Complex Spine Surgery
12:00am, Tuesday, 23'rd Jun 2020
Carlsmed Raises $2.5M to Improve Complex Spine Surgery; funds will be deployed to commercialize its data driven surgery mission, CFO and CIO added.
BIOLASE, Inc. Informs Stockholders of Key Dates and Terms Related to Announced Rights Offering
10:30am, Monday, 22'nd Jun 2020
BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, today provided an informational update to stockholders regarding its proposed rights offering and the expected key dates and terms relat
Paragonix Technologies Announces Appointment of Alexander K. Arrow, MD, CFA to the Board of Directors
12:00am, Monday, 22'nd Jun 2020
Paragonix Technologies, Inc. a commercial stage company and leader in organ preservation and transport technology, today announced that Alexander K. A
Dientes nuevos en un solo día: la nueva (y revolucionaria) solución estética
11:42am, Friday, 19'th Jun 2020
Desde Clínica Dental Asián, en Sevilla, ofrecen uno de los servicios en implantología más revolucionarios y vanguardistas de toda Andalucía
BIOLASE (NASDAQ:BIOL) Share Price Crosses Above Two Hundred Day Moving Average of $0.54
02:32am, Thursday, 18'th Jun 2020
Shares of BIOLASE Inc (NASDAQ:BIOL) passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $0.54 and traded as high as $0.55. B
BIOLASE, Inc. Announces Closing of $6.9 Million Registered Direct Offering Priced At-The-Market
10:30am, Thursday, 11'th Jun 2020
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced the closing on June 10, 2020 of its previously announced registered direct offering of approximately $6.9 million of i
BIOLASE, Inc. Announces Pricing of $6.9M Registered Direct Offering Priced At-The-Market; Priced At $0.64 Per Share
03:02pm, Monday, 08'th Jun 2020BIOLASE, Inc. Announces Pricing of $6.9 Million Registered Direct Offering Priced At-The-Market
03:00pm, Monday, 08'th Jun 2020
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has entered into a securities purchase agreement with institutional investors to purchase approximately $6.9 m
